[1] Koudougou C,Bonneville M,Matysiak-Budnik T,et al. Review article:antitumoural immunity in colorectal cancer-current and potential future implications in clinical practice[J].Aliment Pharmacol Ther,2013,38(1):3-15. [2] Ichikawa M,Chen L.Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity:novel cancer escaping mechanisms[J].Front Biosci,2005,10:2856-2860. [3] Mirza N,Duque MA,Dominguez AL,et al.B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals[J].J Immunol,2010,184(10):5466-5474. [4] Zang X,Thompson RH,Al-Ahmadie HA,et al.B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome[J].Proc Natl Acad Sci USA,2007,104(49):19458-19463. [5] Janakiram M,Abadi YM,Sparano JA,et al.T cell coinhibition and immunotherapy in human breast cancer[J].Discov Med,2012,14(77):229-236. [6] Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3[J].Science,2003,299(5609):1057-1061. [7] Nomura T,Sakaguchi S.Naturally arising CD4+ CD25+ regulartory T cells in tumor immunity[J].Curr Top Microbiol Immunol,2005,293:287-302. [8] Ni XY,Sui HX,Liu Y,et al.TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation[J].Oncol Rep,2012,28(2):615-621. [9] Kristensen NN,Schmidt EG,Rasmussen S,et al.B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells[J].Immunopharmacol Immunotoxicol,2013,35(4):505-513. [10] Huang H,Li C,Ren G.Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer[J].Gene,2017,623:24-28. [11] Park JJ, Omiya R,Matsumura Y,et al.B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance[J].Blood,2010,116(8):1291-1298. [12] Akimova T,Levine MH,Beier UH,et al.Standardization,evaluation,and area-under-curve analysis of human and murine Treg suppressive function[J].Methods Mol Biol,2016,1371(1):43-78. [13] Zhao LW,Li C,Zhang RL,et al.B7-H1andB7-H4expression in colorectal carcinoma:correlation with tumor Foxp3+ regulatory T-cell infiltration[J].Acta Histochem, 2014,116 (7):1163-1168. [14] Xu M,Zhang B,Zhang M,et al.Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer[J].Oncol Lett,2015,11(4):2815-2819. [15] Wang X,Hao J,Metzger DL,et al.B7-H4 treatment of T cells inhibits ERK,JNK,p38,and AKT activation[J].PLoS One,2012,7(1):e28232. [16] Parsa AT,Bloch O,Crane C,et al.Gliomas promote induction of b7-h1/pd-l1 expression on monocytes:clinical evidence of an immunosuppressive mechanism that can be targeted with antibody blockade[J].Neuro Oncol,2014,16:iii41. [17] Zhang C,Li Y,Wang Y.Diagnostic value of serum B7-H4 for hepatocellular carcinoma[J].J Surg Res,2015,197 (2):301-306. [18] Groeger S,Jarzina F,Mamat U,et al.Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells[J].Immunobiology,2017,222(2):137-147. [19] Hirunwidchayarat W,Furusawa E,Kang S,et al.Site-specific regulation of oral mucosa-recruiting CD8+ T cells in a mouse contact allergy model[J].Biochem Biophys Res Commun,2017,490(4):1294-1300. [20] Zou W,Chen L.Inhibitory B7-family molecules in the tumour microenvironment[J].Nat Rev Immunol,2008,8(6):467-477. |